Search research articles
Contact Us
Filters
Showing results (261-270 of 315) with videos related to
Page
of 32
Sort By:
Human Pathology
|
October 3, 2000
Pathology residents' use of a Web-based tutorial to improve Gleason grading of prostate carcinoma on needle biopsies
J D Kronz, M A Silberman, W C Allsbrook, et al.
Cancer Research Communications
|
November 7, 2022
Comprehensive assessment of anaplastic lymphoma kinase in localized and metastatic prostate cancer reveals targetable alterations
Radhika A Patel, Ilsa Coleman, Martine P Roudier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2017
Association of Tissue Abiraterone Levels and <i>SLCO</i> Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer
Elahe A Mostaghel, Eunpi Cho, Ailin Zhang, et al.
Molecular Biology of the Cell
|
January 22, 2025
The kinesin Kar3 is required for endoplasmic reticulum-associated degradation
Emmanuel Akoto, Ellen M Doss, Kieran P Claypool, et al.
Cancer Research Communications
|
October 12, 2023
Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers
Ailin Zhang, Nathan A Lau, Alicia Wong, et al.
The Journal of Clinical Investigation
|
October 19, 2018
Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
Adam Sharp, Ilsa Coleman, Wei Yuan, et al.
JCO Precision Oncology
|
May 25, 2019
Genomic Characterization of Prostatic Ductal Adenocarcinoma Identifies a High Prevalence of DNA Repair Gene Mutations
Michael T Schweizer, Emmanuel S Antonarakis, Tarek A Bismar, et al.
The Journal of Clinical Investigation
|
September 19, 2023
Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer models
Supreet Agarwal, Lei Fang, Kerry McGowen, et al.
The Prostate
|
March 23, 2021
Targeting backdoor androgen synthesis through AKR1C3 inhibition: A presurgical hormonal ablative neoadjuvant trial in high-risk localized prostate cancer
Laura S Graham, Lawrence D True, Roman Gulati, et al.
Nature Medicine
|
March 2, 2016
Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
Akash Kumar, Ilsa Coleman, Colm Morrissey, et al.
Page
of 32
Search research articles
Search
Showing results (261-270 of 315) with videos related to
Sort By:
Page
of 32
Human Pathology
|
October 3, 2000
Pathology residents' use of a Web-based tutorial to improve Gleason grading of prostate carcinoma on needle biopsies
J D Kronz, M A Silberman, W C Allsbrook, et al.
Cancer Research Communications
|
November 7, 2022
Comprehensive assessment of anaplastic lymphoma kinase in localized and metastatic prostate cancer reveals targetable alterations
Radhika A Patel, Ilsa Coleman, Martine P Roudier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2017
Association of Tissue Abiraterone Levels and <i>SLCO</i> Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer
Elahe A Mostaghel, Eunpi Cho, Ailin Zhang, et al.
Molecular Biology of the Cell
|
January 22, 2025
The kinesin Kar3 is required for endoplasmic reticulum-associated degradation
Emmanuel Akoto, Ellen M Doss, Kieran P Claypool, et al.
Cancer Research Communications
|
October 12, 2023
Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers
Ailin Zhang, Nathan A Lau, Alicia Wong, et al.
The Journal of Clinical Investigation
|
October 19, 2018
Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
Adam Sharp, Ilsa Coleman, Wei Yuan, et al.
JCO Precision Oncology
|
May 25, 2019
Genomic Characterization of Prostatic Ductal Adenocarcinoma Identifies a High Prevalence of DNA Repair Gene Mutations
Michael T Schweizer, Emmanuel S Antonarakis, Tarek A Bismar, et al.
The Journal of Clinical Investigation
|
September 19, 2023
Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer models
Supreet Agarwal, Lei Fang, Kerry McGowen, et al.
The Prostate
|
March 23, 2021
Targeting backdoor androgen synthesis through AKR1C3 inhibition: A presurgical hormonal ablative neoadjuvant trial in high-risk localized prostate cancer
Laura S Graham, Lawrence D True, Roman Gulati, et al.
Nature Medicine
|
March 2, 2016
Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
Akash Kumar, Ilsa Coleman, Colm Morrissey, et al.
Page
of 32